WASHINGTON — Biotech breakthroughs are within U.S. reach, but policy shifts and proposed funding cuts could slow how those ...
Biotech researchers are making strides in areas from living neural networks to novel cancer vaccines, but regulatory acceptance lags behind scientific innovation. Disputes over the use of biomarkers ...
The National Academies of Sciences, Engineering, and Medicine will convene an ad hoc study Committee on Biotechnology Capabilities for National Security Needs--Leveraging Advances in Transdisciplinary ...
A New Orleans-based biotech company has developed a breakthrough non-opioid pain medication, which is backed by funding from Ochsner Ventures, the investment arm of Ochsner Health, and from Gulf South ...
The life sciences industry is experiencing transformative shifts driven by technological innovation and urgent global health needs. AAA Biotech, a leading provider of premium research reagents, is ...
Potential breakthrough therapeutic for estimated $50+ billion global immunotherapy market; first and only telomere-targeting anticancer agent in clinical development anywhere CHICAGO, Jan. 20, 2026 ...
A new biosensor developed at the Department of Energy's Oak Ridge National Laboratory detects the emerging presence of fungus on plants at the molecular level, paving the way for next-generation crop ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results